Statement
27 May 2024
WHA77 constituency statement on NCDs and UHC
On 27 May 2024, IFPMA, IGBA, DITTA, GSCF, WHL, and PATH submitted a constituency statement to the World Health Assembly on Provisional Agenda Item 11.2, NCDs and UHC. IFPMA, IGBA, DITTA, GSCF, WHL, and PATH welcome the agenda item on non-communicable diseases (NCDs) and WHO’s continued commitment to this global health challenge. A life-course approach...
Read more
Statement
11 Mar 2024
Delivering equitable access in pandemics: Biopharmaceutical industry commitments
In response to the threat of future global pandemics, the biopharmaceutical industry developed a set of commitments for equitable access to essential medical countermeasures in future pandemics.
Read more
Statement
8 Mar 2024
Resumed session of the 7th Meeting of the Working Group on Amendments to the International Health Regulations (2005)
On 8 March 2024, IFPMA delivered a statement at the resumed session of the 7th Meeting of the Working Group on Amendments to the International Health Regulations in Geneva, where the focus of discussions was on equity.
Read more
